Table 5.
Comparison of G1-2 adverse events between TRT and non-TRT group
| Adverse Events | TRT Group (n = 99) |
non-TRT Group (n = 98) |
P value |
|---|---|---|---|
| Any Grades | 82 (82.8%) | 82 (83.7%) | 0.874 |
| G1-2 Totally | 78 (78.8%) | 78 (79.6%) | 0.889 |
|
Leucopenia /White-cell count decreased |
44 (44.4%) | 34 (34.7%) | 0.190 |
|
Neutropenia /Neutrophil count decreased |
23 (23.2%) | 21 (21.4%) | 0.864 |
|
Thrombocytopenia /Platelet count decreased |
7 (7.1%) | 2 (2.0%) | 0.170 |
| Anaemia | 5 (5.1%) | 13 (13.3%) | 0.051 |
| Nausea | 27 (27.3%) | 25 (25.5%) | 0.872 |
| Decreased appetite | 17 (17.2%) | 28 (28.6%) | 0.063 |
| Constipation | 9 (9.1%) | 14 (14.3%) | 0.276 |
| Diarrhea | 6 (6.1%) | 7 (7.1%) | 0.783 |
| Radiation esophagitis | 38 (38.4%) | / | / |
| Pneumonitis | 16 (16.2%) | 9 (9.2%) | 0.199 |
| Myocarditis | 0 (0%) | 0 (0%) | / |
| Hypothyroid | 1 (1.0%) | 1 (1.0%) | 1.000 |
| Atrial fibrillation | 0 (0%) | 0 (0%) | / |
G1-2: grade 1 to 2